In the AD brain, high levels of Aβ or abnormal tau accumulation along with excessive reactive oxygen species, increased energetic demand, and mitochondrial dysfunction may alter the consequences of Willin/FRMD6 knockdown. The gene discussed is MAPT; the disease is Alzheimer disease.